These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 17693049

  • 1. Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer.
    Bria E, Visca P, Novelli F, Casini B, Diodoro MG, Perrone-Donnorso R, Botti C, Sperduti I, Facciolo F, Milella M, Cecere FL, Cognetti F, Mottolese M.
    Eur J Surg Oncol; 2008 May; 34(5):593-8. PubMed ID: 17693049
    [Abstract] [Full Text] [Related]

  • 2. Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma.
    Shinohara ET, Gonzalez A, Massion PP, Chen H, Li M, Freyer AS, Olson SJ, Andersen JJ, Shyr Y, Carbone DP, Johnson DH, Hallahan DE, Lu B.
    Cancer; 2005 Apr 15; 103(8):1685-92. PubMed ID: 15742356
    [Abstract] [Full Text] [Related]

  • 3. Survivin gene expression in early-stage non-small cell lung cancer.
    Falleni M, Pellegrini C, Marchetti A, Oprandi B, Buttitta F, Barassi F, Santambrogio L, Coggi G, Bosari S.
    J Pathol; 2003 Aug 15; 200(5):620-6. PubMed ID: 12898598
    [Abstract] [Full Text] [Related]

  • 4. Correlation between survivin expression and prognosis in non-small cell lung cancer.
    Atikcan S, Unsal E, Demirag F, Köksal D, Yilmaz A.
    Respir Med; 2006 Dec 15; 100(12):2220-6. PubMed ID: 16650973
    [Abstract] [Full Text] [Related]

  • 5. The role of survivin on overall survival of non-small cell lung cancer, a meta-analysis of published literatures.
    Fan J, Wang L, Jiang GN, He WX, Ding JA.
    Lung Cancer; 2008 Jul 15; 61(1):91-6. PubMed ID: 18192073
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of survivin, X-linked inhibitor of apoptosis protein and second mitochondria-derived activator of caspases expression in advanced non-small-cell lung cancer patients.
    Chen P, Li J, Ge LP, Dai CH, Li XQ.
    Respirology; 2010 Apr 15; 15(3):501-9. PubMed ID: 20210890
    [Abstract] [Full Text] [Related]

  • 7. Cytoplasmic clusterin expression is associated with longer survival in patients with resected non small cell lung cancer.
    Albert JM, Gonzalez A, Massion PP, Chen H, Olson SJ, Shyr Y, Diaz R, Lambright ES, Sandler A, Carbone DP, Putnam JB, Johnson DH, Lu B.
    Cancer Epidemiol Biomarkers Prev; 2007 Sep 15; 16(9):1845-51. PubMed ID: 17855704
    [Abstract] [Full Text] [Related]

  • 8. Up-regulation of survivin mRNA might be a marker for non-invasive detection of non-small cell lung cancer rather than for prognosis.
    Warnecke-Eberz U, Baldus SE, Bollschweiler E, Hoelscher AH, Metzger R.
    Anticancer Res; 2008 Sep 15; 28(3A):1525-9. PubMed ID: 18630507
    [Abstract] [Full Text] [Related]

  • 9. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S, Yasufuku K, Hiroshima K, Nakajima T, Yoshida S, Suzuki M, Sekine Y, Shibuya K, Iizasa T, Farouk A, Fujisawa T.
    Cancer; 2007 Jun 15; 109(12):2506-14. PubMed ID: 17487846
    [Abstract] [Full Text] [Related]

  • 10. Survivin and Smac gene expressions but not livin are predictors of prognosis in non-small cell lung cancer patients treated with adjuvant chemotherapy following surgery.
    Dai CH, Li J, Shi SB, Yu LC, Ge LP, Chen P.
    Jpn J Clin Oncol; 2010 Apr 15; 40(4):327-35. PubMed ID: 20056675
    [Abstract] [Full Text] [Related]

  • 11. Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy.
    Leithner K, Stacher E, Wurm R, Ploner F, Quehenberger F, Wohlkoenig C, Bálint Z, Polachova J, Olschewski A, Samonigg H, Popper HH, Olschewski H.
    Lung Cancer; 2009 Jul 15; 65(1):98-104. PubMed ID: 19081160
    [Abstract] [Full Text] [Related]

  • 12. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer.
    Huang CL, Liu D, Nakano J, Yokomise H, Ueno M, Kadota K, Wada H.
    Clin Cancer Res; 2007 Dec 01; 13(23):6938-46. PubMed ID: 18056168
    [Abstract] [Full Text] [Related]

  • 13. Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients.
    Ferreira CG, van der Valk P, Span SW, Ludwig I, Smit EF, Kruyt FA, Pinedo HM, van Tinteren H, Giaccone G.
    Clin Cancer Res; 2001 Aug 01; 7(8):2468-74. PubMed ID: 11489828
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of polysialic acid expression in resected non-small cell lung cancer.
    Tanaka F, Otake Y, Nakagawa T, Kawano Y, Miyahara R, Li M, Yanagihara K, Inui K, Oyanagi H, Yamada T, Nakayama J, Fujimoto I, Ikenaka K, Wada H.
    Cancer Res; 2001 Feb 15; 61(4):1666-70. PubMed ID: 11245481
    [Abstract] [Full Text] [Related]

  • 15. Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer.
    Derin D, Soydinç HO, Guney N, Tas F, Camlica H, Duranyildiz D, Yasasever V, Topuz E.
    Lung Cancer; 2008 Feb 15; 59(2):240-5. PubMed ID: 17875341
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical detection of nuclear survivin in NSCLC: a comparison of commercial antibodies.
    Vischioni B, Oudejans JJ, Kruyt FA, Giaccone G, Rodriguez JA.
    Histopathology; 2007 Apr 15; 50(5):671-5. PubMed ID: 17394508
    [No Abstract] [Full Text] [Related]

  • 17. Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer.
    Hofmann HS, Simm A, Hammer A, Silber RE, Bartling B.
    J Cancer Res Clin Oncol; 2002 Oct 15; 128(10):554-60. PubMed ID: 12384799
    [Abstract] [Full Text] [Related]

  • 18. Survivin expression and its relationship with apoptosis and prognosis in nasal and paranasal sinus carcinomas.
    Zhang Y, Huang D, Yu G.
    Acta Otolaryngol; 2005 Dec 15; 125(12):1345-50. PubMed ID: 16303685
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of expression of p53 oncoprotein in primary (stage I-IIIa) non-small cell lung cancer.
    Tan DF, Li Q, Rammath N, Beck A, Wiseman S, Anderson T, al-Salameh A, Brooks J, Bepler G.
    Anticancer Res; 2003 Dec 15; 23(2C):1665-72. PubMed ID: 12820438
    [Abstract] [Full Text] [Related]

  • 20. [Prognostic value of expression of FASE, HER-2/neu, bcl-2 and p53 in stage I non-small cell lung cancer].
    Wang Y, Zhang XR, Fu J, Tan W, Zhang W.
    Zhonghua Zhong Liu Za Zhi; 2004 Jun 15; 26(6):369-72. PubMed ID: 15312350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.